REPORT ID 447

EMEA (Europe, Middle East and Africa) Progesterone Market Report 2017

Publish Date
01-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the EMEA Progesterone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Progesterone for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Progesterone market competition by top manufacturers/players, with Progesterone sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Merck Serono
    Solvay
    Glaxosmithkline
    Sanofi Aventis
    Actavis
    Xianju Pharma
    Asen
    Chenggu Zhenhua Bio-Tech
    Kaitai Hormone
    Zhejiang Medicine Xinchang
    Hongyuan Pharmaceutical
    Senzu
    Hubei Fangtong Pharmaceutical
    Kaitai Hormone
    Xian Gaoyuan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Prevention of Preterm Birth
    Gynecological Disorders
    Other Uses

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Liauid
    Tablets

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Progesterone Market Report 2017
1 Progesterone Overview
    1.1 Product Overview and Scope of Progesterone
    1.2 Classification of Progesterone
        1.2.1 EMEA Progesterone Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Progesterone Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Prevention of Preterm Birth
        1.2.4 Gynecological Disorders
        1.2.5 Other Uses
    1.3 EMEA Progesterone Market by Application/End Users
        1.3.1 EMEA Progesterone Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Liauid
        1.3.3 Tablets
    1.4 EMEA Progesterone Market by Region
        1.4.1 EMEA Progesterone Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Progesterone (2012-2022)
        1.5.1 EMEA Progesterone Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Progesterone Revenue and Growth Rate (2012-2022)

2 EMEA Progesterone Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Progesterone Market Competition by Players/Manufacturers
        2.1.1 EMEA Progesterone Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Progesterone Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Progesterone Sale Price by Players (2012-2017)
    2.2 EMEA Progesterone (Volume and Value) by Type/Product Category
        2.2.1 EMEA Progesterone Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Progesterone Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Progesterone Sale Price by Type (2012-2017)
    2.3 EMEA Progesterone (Volume) by Application
    2.4 EMEA Progesterone (Volume and Value) by Region
        2.4.1 EMEA Progesterone Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Progesterone Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Progesterone Sales Price by Region (2012-2017)

3 Europe Progesterone (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Progesterone Sales and Value (2012-2017)
        3.1.1 Europe Progesterone Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Progesterone Revenue and Growth Rate (2012-2017)
    3.2 Europe Progesterone Sales and Market Share by Type
    3.3 Europe Progesterone Sales and Market Share by Application
    3.4 Europe Progesterone Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Progesterone Sales Volume by Countries (2012-2017)
        3.4.2 Europe Progesterone Revenue by Countries (2012-2017)
        3.4.3 Germany Progesterone Sales and Growth Rate (2012-2017)
        3.4.4 France Progesterone Sales and Growth Rate (2012-2017)
        3.4.5 UK Progesterone Sales and Growth Rate (2012-2017)
        3.4.6 Russia Progesterone Sales and Growth Rate (2012-2017)
        3.4.7 Italy Progesterone Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Progesterone Sales and Growth Rate (2012-2017)

4 Middle East Progesterone (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Progesterone Sales and Value (2012-2017)
        4.1.1 Middle East Progesterone Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Progesterone Revenue and Growth Rate (2012-2017)
    4.2 Middle East Progesterone Sales and Market Share by Type
    4.3 Middle East Progesterone Sales and Market Share by Application
    4.4 Middle East Progesterone Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Progesterone Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Progesterone Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Progesterone Sales and Growth Rate (2012-2017)
        4.4.4 Israel Progesterone Sales and Growth Rate (2012-2017)
        4.4.5 UAE Progesterone Sales and Growth Rate (2012-2017)
        4.4.6 Iran Progesterone Sales and Growth Rate (2012-2017)

5 Africa Progesterone (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Progesterone Sales and Value (2012-2017)
        5.1.1 Africa Progesterone Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Progesterone Revenue and Growth Rate (2012-2017)
    5.2 Africa Progesterone Sales and Market Share by Type
    5.3 Africa Progesterone Sales and Market Share by Application
    5.4 Africa Progesterone Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Progesterone Sales Volume by Countries (2012-2017)
        5.4.2 Africa Progesterone Revenue by Countries (2012-2017)
        5.4.3 South Africa Progesterone Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Progesterone Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Progesterone Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Progesterone Sales and Growth Rate (2012-2017)

6 EMEA Progesterone Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Progesterone Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck Serono
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Progesterone Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Serono Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Solvay
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Progesterone Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Solvay Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Glaxosmithkline
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Progesterone Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Glaxosmithkline Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi Aventis
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Progesterone Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi Aventis Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Actavis
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Progesterone Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Actavis Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Xianju Pharma
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Progesterone Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Xianju Pharma Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Asen
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Progesterone Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Asen Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Chenggu Zhenhua Bio-Tech
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Progesterone Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Chenggu Zhenhua Bio-Tech Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Kaitai Hormone
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Progesterone Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Kaitai Hormone Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Zhejiang Medicine Xinchang
    6.12 Hongyuan Pharmaceutical
    6.13 Senzu
    6.14 Hubei Fangtong Pharmaceutical
    6.15 Kaitai Hormone
    6.16 Xian Gaoyuan

7 Progesterone Manufacturing Cost Analysis
    7.1 Progesterone Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Progesterone

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Progesterone Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Progesterone Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Progesterone Market Forecast (2017-2022)
    11.1 EMEA Progesterone Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Progesterone Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Progesterone Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Progesterone Price and Trend Forecast (2017-2022)
    11.2 EMEA Progesterone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Progesterone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Progesterone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Progesterone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Progesterone Sales Forecast by Type (2017-2022)
    11.7 EMEA Progesterone Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer